Nivolumab and relatlimab as frontline therapy in advanced melanoma.

Subjects

Subjects :

Antibodies, Monoclonal adverse effects
Antineoplastic Combined Chemotherapy Protocols
Humans
Ipilimumab therapeutic use
Nivolumab therapeutic use
Melanoma drug therapy
Skin Neoplasms drug therapy

Details

Language :

English

ISSN :

1543-0790

Volume :

20

Issue :

10

Database :

MEDLINE

Journal :

Clinical advances in hematology & oncology : H&O

Accession number :

36206071